...
首页> 外文期刊>Japanese journal of infectious diseases >Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
【24h】

Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.

机译:结核菌素皮肤试验和T-SPOT.TB诊断潜伏性和活动性结核的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

The T-SPOT.TB test does not cross-react with Bacille Calmette-Guerin or most non-tuberculosis mycobacterium species, and is based on IFN-gamma responses to Mycobacterium tuberculosis-specific antigens. The objective of this study was to compare tuberculin skin test (TST) with T-SPOT.TB results used in the diagnosis of active tuberculosis (TB) as well as latent tuberculosis infection (LTBI). A total of 136 subjects participated in three different groups (47 patients with active pulmonary TB, 47 healthy persons without M. tuberculosis exposure, and 42 hospital members with a history of close contact with active TB patients). The T-SPOT.TB sensitivity (83.0%) and the negative predictive value (NPV) (82.6%) in the diagnosis of active TB were significantly higher than those of TST. The sensitivity and NPV of the TST were 38.3 and 60.8%, respectively. The T-SPOT.TB specificity (80.9%) and positive predictive value (81.3%) were lower than those of TST (95.7 and 90.0%, respectively). The performance of T-SPOT.TB and TST for diagnosing LTBI was the same (54.8%). T-SPOT.TB was superior in terms of sensitivity (83.0%); TST detected only 18, whereas T-SPOT.TB test detected 39 out of 47 patients with active TB. T-SPOT.TB is thought to have better performance than TST due to false-negative results in diagnosing active TB. However, it is considered that large prospective longitudinal studies are needed for diagnosing LTBI.
机译:T-SPOT.TB测试不会与卡介苗-芽孢杆菌或大多数非结核分枝杆菌种发生交叉反应,并且基于IFN-γ对结核分枝杆菌特异性抗原的反应。这项研究的目的是比较结核菌素皮肤试验(TST)和T-SPOT.TB结果用于诊断活动性结核病(TB)和潜伏性结核感染(LTBI)。共有136名受试者参加了三个不同的小组(47例活动性肺结核患者,47例未接触结核分枝杆菌的健康人和42例与活动性结核病患者密切接触的医院成员)。 T-SPOT.TB在活动性结核病诊断中的敏感性(83.0%)和阴性预测值(NPV)(82.6%)显着高于TST。 TST的灵敏度和NPV分别为38.3和60.8%。 T-SPOT.TB特异性(80.9%)和阳性预测值(81.3%)低于TST(分别为95.7%和90.0%)。 T-SPOT.TB和TST诊断LTBI的性能相同(54.8%)。 T-SPOT.TB的敏感性更高(83.0%); TST仅检测到18位患者,而T-SPOT.TB测试仅检测到47位活动性结核患者中的39位。 T-SPOT.TB被认为比TST具有更好的性能,这是由于在诊断活动性TB时出现假阴性结果。但是,认为需要大量的前瞻性纵向研究来诊断LTBI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号